Currently in shortage
AstraZeneca device component shortage affecting Turbuhaler production. Symbicort Rapihaler unaffected.
Expected resolution: 31 October 2025
Alternatives:
- Symbicort Rapihaler 200/6 — same medicine, different device
- Seretide Accuhaler (salmeterol/fluticasone) — different ICS/LABA combination
- Breo Ellipta (fluticasone furoate/vilanterol)
budesonide + formoterol
Symbicort
200/6 mcg/dose · dry powder inhaler · Combination Inhalers
PBS Pricing
| General patient co-payment | $31.60 |
| Concession co-payment | $7.70 |
| Full dispensed price | $58.80 |
PBS Information
- Item code
- 5333D
- Drug name
- budesonide + formoterol
- Brand name
- Symbicort
- Manufacturer
- AstraZeneca
- Formulation
- dry powder inhaler
- Strength
- 200/6 mcg/dose
- Max quantity
- 1 units
- Max repeats
- 5
- PBS listed
- Yes
- Therapeutic group
- Combination Inhalers
TGA Reference: TGA-MSI-2025-029 · Sponsor: AstraZeneca Pty Ltd
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.